TAN 684

Drug Profile

TAN 684

Latest Information Update: 31 Aug 2007

Price : $50

At a glance

  • Originator Toray
  • Class Analgesics
  • Mechanism of Action Opioid kappa receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Pain

Most Recent Events

  • 18 Dec 2003 No development reported - Preclinical for Pain in Japan (unspecified route)
  • 16 May 2001 A study has been added to the pharmacodynamics section
  • 17 Jan 2000 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top